Mouse spleen cells sequentially agglutinated by soybean agglutinin (SBA) and peanut agglutinin (PNA) previously had been shown to be sufficiently depleted of graftversus-host activity to allow reconstitution of lethally irradiated allogeneic recipient mice. We have now tested the extent of T-cell depletion in this cell fraction by various in vitro assays, including cytotoxicity testing with anti-Thy-i antiserum, mitogenic response to the T-cell mitogens concanavalin A and phytohemagglutinin and allogeneic responsiveness in the mixed lymphocyte culture assay. By these criteria the SBA+, PNA+ spleen fraction, used previously in the in vivo experiments, was found to possess about 1% T-cell contamination. The slight contamination with T cells previously found in the singly agglutinated SBA fraction can be removed by a second fractionation with SBA, thus eliminating the possibility that a minor T-cell subpopulation bears receptors for SBA. Finally, we demonstrate that the twice-agglutinated fraction, by SBA and PNA or by SBA alone, contains a significant number of prothymocytes, thereby indicating that mouse prothymocytes bear receptors for both SBA and PNA. The implication of these findings to bone marrow transplantation in humans is discussed.
In the past few years it has been shown that differential agglutination, by lectins, of different cell subpopulations can serve as a basis for a simple and effective method of cell separation (1- 7) .
This was first demonstrated by the use of peanut agglutinin (PNA) for the fractionation of mouse thymocytes into two subpopulations which differ in many of their surface properties and biological activities (1). It was found that in contrast to most cell types, which are not agglutinated by PNA unless pretreated with neuraminidase, the bulk of the thymus cells were agglutinated by the lectin. Separation of the cell clumps from the single unagglutinated cells was achieved by layering the agglutinated cell mixture on fetal calf serum (20%), whereupon the cell clumps settled to the bottom of the tube and the single cells remained on the top. Upon washing of the separated cell fractions with the sugar inhibitor of PNA, D-galactose, the bound lectin was removed from the cell surface and the agglutinated cells were dissociated into viable single cells.
Examination of the separated cells (surface markers, response to mitogens, immunological activities) showed that the agglutinated thymocytes were essentially identical with the cortical immature cells whereas the nonagglutinated fraction consisted of cells which were similar to the medullar hydrocortisoneresistant mature thymocytes or spleen T cells (1). These findings have been fully confirmed recently by several independent studies (8) (9) (10) (11) .
The use of lectins for cell fractionation was further extended by Reisner et al. (3) for the separation of mouse spleen T and B cells by using soybean agglutinin (SBA) which agglutinates B cells and does not agglutinate T cells. Thus, the unagglutinated fraction consisted mainly of T cells (78%) and was highly depleted of B cells (4%), whereas the agglutinated fraction consisted mainly of B cells (83%) and was depleted of T cells (7%) (3). Subsequently, it was found (4) that the agglutinated fraction is depleted of graft-versus-host (GvH) activity (Simonsen assay) and is enriched with hemopoietic stem cells [spleen colony-forming units (CFU)]. Examination of the binding of fluorescein-labeled PNA to the spleen cells agglutinated by SBA revealed that a subpopulation (about 15%) was stained. Further isolation of the PNA-positive (PNA+) cells from the SBA-agglutinated fraction resulted in additional enrichment for CFUs.
Because neuraminidase treatment of mouse cells or thymocytes unmasks PNA and SBA receptors on 100% of the cells, Sharon and Reisner (12) have postulated that the primitive stem cell in mouse bone marrow and spleen bears receptors for SBA and PNA, the sialylation of which increases with lymphocyte differentiation and maturation (Fig. 1) .
In agreement with this model, it was found recently by Reisner et Also, using double-fractionation with SBA alone, we attempted to find out whether the residual T-cell contamination of the agglutinated fraction, after a single fractionation with SBA, is due merely to trapping T cells in the cell aggregates or whether there is a small T-cell subset that differs from the major, unagglutinated T-cell population. Finally, attempts were made to determine whether prothymocytes are agglutinated by both lectins, as expected from the model proposed by Sharon and Reisner (12 Lectins. PNA and SBA were purified by affinity chromatography on a column of Sepharose-N-(e-aminocaproyl)-f3-D-galactopyranosylamine (13, 14) .
Cell Fractionation with Lectins. The method of Reisner et al. (4) was used with minor modifications. Briefly, the splenocyte suspension (2 X 108 cells in 0.5 ml of PiNaCl) was incubated in polystyrene tubes (17 X 100 mm) with SBA (0.5 ml, 2 mg/ml) for 5 min at room temperature. The cells were then gently layered, with a pasteur pipette, on top of 40 ml of 5% (wt/vol) bovine serum albumin (in Pi/NaCl) in a 50-ml conical glass tube. After 15 min at room temperature, most of the agglutinated cells had sedimented, whereas the unagglutinated cells remained on the surface of the solution. The bottom and top fractions were removed separately with pasteur pipettes and transferred to 15-ml conical plastic tubes. The cells were then suspended in 0.2 M D-galactose in Pi/NaCl. After 10 min at room temperature, the cells were collected by centrifugation (200 X g, 5 min) and washed twice with Pi/NaCl. The SBAagglutinated cells were then subjected to a second fractionation procedure, either with SBA again or with PNA. For the PNA fractionation, cells (1 X 108/0.5 ml of Pi/NaCI) were mixed with rabbit erythrocytes (4 X 108/0.5 ml of Pi/NaCI). The cell mixture (0.5 ml) was incubated with PNA (1 mg/ml in P1/NaCI, 0.5 ml) for 10 (7%) (3) . These results raised the possibility that the T-cell contamination in the agglutinated B-cell fraction may represent a specific subpopulation of T cells that are agglutinated by SBA, unlike the majority of the spleen T cells which are neither agglutinated by nor capable of binding the lectin. (Fig. 3) , that the T-cell contamination was almost completely eliminated from this cell fraction, unlike the hemopoietic activity which was slightly enriched. This finding suggests that the T-cell contamination after a single agglutination step Sharon and Reisner (12) (Fig.  1) , suggesting that SBA and PNA receptors are present on the pluripotential stem cells and are masked by sialic acid in an orderly manner during the late steps of maturation and differentiation, raised the possibility that the prothymocytes, We tested thymosin (fraction V) for its ability to induce Thy-1 antigen on cells of these fractions. About 25% of the cells twice agglutinated with SBA and about 13% of the cells agglutinated by SBA and PNA were induced specifically to express the Thy-1 antigen upon incubation for 90 min with the hormone preparation (Table 4) .
Interestingly, it has been found recently (unpublished results) that, in C57BL/6 mice injected intrathymically with radiation leukemia virus, the PNA-agglutinated spleen fraction contained preleukemic cells (previously shown to be prothymocytes) (17) .
In agreement with the model proposed by Sharon and Reisner (12) , our present findings indicate a possible T-cell line of differentiation in which the PNA and SBA receptors are exposed on the cell surface from a very early stage of differentiation, the pluripotential stem cell. They are also present on the prothymocyte stage and on the immature Thy-i-bearing thymocyte. The mature thymocytes bear receptors only for SBA (the PNA receptor being masked by sialic acid). On the mature spleen T cell, both PNA and SBA receptors appear to be masked by sialic acid.
However, from our present results, we cannot exclude other differentiation pathways involving pluripotential stem cells and prothymocytes, which may be both SBA-and PNA-because the unagglutinated cell fractions comprise mostly mature T cells and cannot be tested for the induction of T-cell differentiation markers.
Finally, it should be noted that the prothymocytes present in the fraction agglutinated by SBA and PNA did not produce delayed GvH disease when transplanted into allogeneic recipients (4), indicating that removal of mature T cells from human bone marrow aspirates may be sufficient to avoid development of GvH disease in allogeneic recipients.
